[1] 朱华忠,朱洪海,殷兆芳等.老年稳定型冠心病患者B型利钠肽分层随访5年结果[J].心血管康复医学杂志,2013,22(5):454-457.
[2] 中华医学会心血管病学分会. 急性心肌梗死诊断和治疗指南[J].中华心血管病杂志, 2001, 29(12):710-725.
[3] 吴国顺. N末端B型钠尿肽原与美国纽约心脏病学会心功能分级在心力衰竭诊断中的相关性对比分析[J].中国医药指南, 2014,12(23):250-251.
[4] 毕云,郭贤利,毛艳阳,等.重组人脑利钠肽联合米力农治疗冠心病室性早搏的效果[J].西南国防医药,2016,26(2):129-131.
[5] Pan Y, Lu ZG, Hang J, et al .Effects of Low-Dose Recombinant Human Brain Natriuretic Peptide on Anterior Myocardial Infarction Complicated by Cardiogenic Shock[J]. Brazilian J Cardiol Surg, 2017, 32(2): 96-103.
[6] He XM, Chen L, Luo JB, et al . Effects of rhBNP after PCI on non-invasive hemodynamic in acute myocardial infarction patients with left heart failure[J]. Asian Pacific J Tropical Med, 2016, 9(8): 791-795.
[7] Mishra RK, Judson G, Christenson RH, et al . The association of five-year changes in the levels of N-terminal fragment of the prohormone brain-type natriuretic peptide (NT-proBNP) with subsequent heart failure and death in patients with stable coronary artery disease: the heart and soul study[J]. Cardiology, 2017, 137(4): 201-206.
[8] 肖志刚,黄敏.重组人脑利钠肽治疗38例老老年慢性心力衰竭的疗效观察[J].中国医药导刊,2013,15(11):1844-1845. |
2018, Vol. 35 
